Home » Authors » James Etheridge

Articles by James Etheridge

ExonHit Sets Up Shop In U.S., Expands Into Heart Diseases

Jan. 31, 2001

By James Etheridge

NiCox Reveals 'Aggressive' Plan For Compounds In Coming Year

Jan. 24, 2001

By James Etheridge

Belgian Firms Tibotec, Virco Plan To Add Mass Via Merger

Jan. 24, 2001

By James Etheridge

Cerep, Four European Companies Align To Create Compound Library

Jan. 24, 2001

By James Etheridge

Belgian Firms Tibotec, Virco Plan To Add Mass Via Merger

Jan. 24, 2001

By James Etheridge

NiCox Reveals 'Aggressive' Plan For Compounds In Coming Year

Jan. 24, 2001

By James Etheridge

Cerep, Four European Companies Align To Create Compound Library

Jan. 24, 2001

By James Etheridge

GenOdyssee Applies For Patents Covering Genetic Variants Method

Jan. 10, 2001

By James Etheridge

Eurofins Beefing Up Detection Business Through Acquisitions

Jan. 10, 2001

By James Etheridge

GenOdyssee Applies For Patents Covering Genetic Variants Method

Jan. 10, 2001

By James Etheridge

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 2, 2026.
AND-017 increases RBC and hemoglobin in sickle cell disease
BioWorld Science
Sickle cell disease (SCD) is an inherited hemoglobinopathy caused by a mutation in the gene encoding β-globin that results in hemoglobin S polymerization, red...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...